Association of resistin and adiponectin with different clinical blood pressure phenotypes. (Q51405508)

4 April 2018

title

Association of resistin and adiponectin with different clinical blood pressure phenotypes. (English)

1 reference

4 April 2018

author name string

C Thomopoulos

1

1 reference

4 April 2018

M Daskalaki

2

1 reference

4 April 2018

O Papazachou

3

1 reference

4 April 2018

N Rodolakis

4

1 reference

4 April 2018

A Bratsas

5

1 reference

4 April 2018

D P Papadopoulos

6

1 reference

4 April 2018

M V Papavasileiou

7

1 reference

4 April 2018

D Perrea

8

1 reference

4 April 2018

T Makris

9

1 reference

4 April 2018

publication date

4 March 2010

1 reference

4 April 2018

Journal of Human Hypertension

published in

1 reference

4 April 2018

volume

25

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

38-46

1 reference

4 April 2018

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Adipose tissue and atherosclerosis: exploring the connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Pleiotropism of adiponectin: inflammation, neovascularization, and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Circulating resistin levels in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Hypoadiponectinemia is an independent risk factor for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Masked hypertension: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Recommendations for chamber quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Free leptin is associated with masked hypertension in nonobese subjects: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Masked hypertension and atherogenesis: the impact on adiponectin and resistin plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Adiponectin--insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Resistin impairs insulin-evoked vasodilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Association of hypoadiponectinemia with impaired vasoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Association between serum resistin and carotid intima media thickness in hypertension patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Role of resistin in cardiac contractility and hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Long-term risk of sustained hypertension in white-coat or masked hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

7 January 2021

Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

7 January 2021

Absence of any significant effects of circadian blood pressure variations on carotid artery elastic properties in essential hypertensive subjects

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

7 January 2021

Adiponectin and resistin plasma levels in healthy individuals with prehypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

7 January 2021

Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

7 January 2021

Obesity-associated hypertension: new insights into mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

7 January 2021

Association of hypoadiponectinemia with coronary artery disease in men

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

7 January 2021

Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.22

7 January 2021

Identifiers

DOI

10.1038/JHH.2010.22

1 reference

4 April 2018

1 reference

4 April 2018